Skip to main content

Table 2 Univariate Analyses in the Discovery Cohort

From: AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report

Variable

Complete Response, CR (N = 185)

Overall Survival, OS (N = 185)

Relapse-Free Survival, RFS (N = 106)

OR (95% CI)

P

HR (95% CI)

P

HR (95% CI)

P

Age

Continuous

0.96 (0.94–0.98)

< 0.001

1.06 (1.04–1.07)

< 0.001

1.04 (1.02–1.05)

< 0.001

By Decade

0.66 (0.53–0.82)

< 0.001

1.75 (1.52–2.01)

< 0.001

1.41 (1.20–1.67)

< 0.001

Cytogenetics

Fav. vs. Interm.

5.29 (1.15–24.40)

0.033*

0.24 (0.10–0.59)

0.002*

0.29 (0.12–0.69)

0.005*

Unfav. vs. Interm.

0.42 (0.18–0.97)

0.043*

1.77 (1.12–2.79)

0.014*

1.38 (0.71–2.68)

0.349*

Unk. vs. Interm.

0.57 (0.28–1.16)

0.124*

1.25 (0.84–1.88)

0.271*

0.80 (0.46–1.41)

0.446*

Performance Status

Numeric

0.82 (0.58–1.15)

0.246

1.07 (0.89–1.30)

0.462

0.84 (0.62–1.15)

0.278

2–3 vs. 0–1

0.37 (0.17–0.81)

0.013

1.49 (0.97–2.29)

0.07

1.01 (0.50–2.03)

0.971

Study

S0106 vs S9031

2.88 (1.20–6.87)

0.018*

0.28 (0.17–0.46)

< 0.001*

0.35 (0.18–0.69)

0.002*

S9333 vs S9031

1.04 (0.40–2.73)

0.934*

0.87 (0.53–1.43)

0.58*

0.79 (0.38–1.67)

0.54*

S0112 vs S9031

0.63 (0.17–2.33)

0.484*

1.16 (0.61–2.22)

0.645*

0.79 (0.27–2.30)

0.669*

Immunophenotype

2 vs 0

1.37 (0.68–2.75)

0.384

1.14 (0.77–1.70)

0.504

1.26 (0.76–2.08)

0.373

1 vs 0

0.73 (0.33–1.57)

0.415

1.02 (0.64–1.61)

0.946

0.97 (0.51–1.86)

0.928

AML Onset

Secondary vs. DN

0.23 (0.08–0.67)

0.007

1.89 (1.10–3.25)

0.02

0.95 (0.30–3.01)

0.925

ELN2017 in MNCs

Fav. vs. Interm.

3.11 (1.16–8.32)

0.024*

0.58 (0.32–1.02)

0.06*

0.47 (0.24–0.92)

0.027*

Adv. vs. Interm.

0.64 (0.27–1.56)

0.328*

1.66 (1.00–2.77)

0.05*

1.72 (0.88–3.35)

0.113*

Unk. vs. Interm.

0.72 (0.29–1.75)

0.467*

1.32 (0.78–2.23)

0.305*

0.76 (0.37–1.54)

0.441*

ELN2017 in VLBs

Fav. vs. Interm.

3.69 (1.30–10.52)

0.014*

0.38 (0.21–0.68)

0.001*

0.37 (0.18–0.77)

0.008*

Adv. vs. Interm.

0.77 (0.30–1.98)

0.587*

1.10 (0.66–1.84)

0.72*

1.45 (0.71–2.97)

0.312*

Unk. vs. Interm.

0.96 (0.37–2.47)

0.928*

0.78 (0.46–1.33)

0.36*

0.64 (0.31–1.35)

0.242*

  1. * Indicates that the overall p-value was significant (< 0.05)